Vicapsys Life Sciences
$1.4600
0
-$0.00-0% Thursday 20:00
Statistics
Day High
0.51
Day Low
0.51
52W High
1.77
52W Low
0.15
Volume
100
Avg. Volume
0
Mkt Cap
47.26M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.02
-0.01
-0.01
0
Expected EPS
N/A
Actual EPS
-0.0064
Financials
-Profit Margin
Unprofitable0Revenue
-1.98MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
Show more...
CEO
Mr. Federico Pier
Employees
2
Country
United States
ISIN
US92560A1060
Listings
0 Comments
Share your thoughts
FAQ
What is Vicapsys Life Sciences stock price today?▼
The current price of VICP is $1.46 USD — it has decreased by -0% in the past 24 hours. Watch Vicapsys Life Sciences stock price performance more closely on the chart.
What is Vicapsys Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Vicapsys Life Sciences stocks are traded under the ticker VICP.
Is Vicapsys Life Sciences stock price growing?▼
VICP stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Vicapsys Life Sciences has showed a -17.51% decrease.
What is Vicapsys Life Sciences market cap?▼
Today Vicapsys Life Sciences has the market capitalization of 47.26M
What were Vicapsys Life Sciences earnings last quarter?▼
VICP earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vicapsys Life Sciences revenue for the last year?▼
Vicapsys Life Sciences revenue for the last year amounts to 0 USD.
What is Vicapsys Life Sciences net income for the last year?▼
VICP net income for the last year is -1.98M USD.
How many employees does Vicapsys Life Sciences have?▼
As of July 20, 2026, the company has 2 employees.
In which sector is Vicapsys Life Sciences located?▼
Vicapsys Life Sciences operates in the Health & Wellness sector.
When did Vicapsys Life Sciences complete a stock split?▼
The last stock split for Vicapsys Life Sciences was on November 02, 2017 with a ratio of 1:100.
Where is Vicapsys Life Sciences headquartered?▼
Vicapsys Life Sciences is headquartered in Suwanee, United States.